{"id":375,"date":"2021-01-05T11:57:19","date_gmt":"2021-01-05T10:57:19","guid":{"rendered":"http:\/\/www.healthtech.pl\/?page_id=375"},"modified":"2021-10-13T10:47:01","modified_gmt":"2021-10-13T08:47:01","slug":"iba-eng","status":"publish","type":"page","link":"https:\/\/www.healthtech.pl\/?page_id=375&lang=en","title":{"rendered":"IBA ENG"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\"><strong>IBA &#8211; Solution for radiopharmacy<\/strong><\/h1>\n\n\n\n<p>The IBA S.A. is present for more than 30 year on the market. It is a global leader for contemporary solutions for radio pharmacy and proton beam therapy.<\/p>\n\n\n\n<p>IBA\u2019s portfolio consists of wide range of cyclotrons for SPECT and PET radioisotope production with proton energy from 18 MeV up to 70 MeV. IBA\u2019s cyclotrons are installed in more than 260 countries all over the globe.<\/p>\n\n\n\n<p>IBA\u2019s cyclotrons can be equipped with variety of target systems (liquid, gas or solid-state) for production of almost all isotopes for medical diagnostics and therapy.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"681\" src=\"http:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/kiube-1024x681.png\" alt=\"\" class=\"wp-image-297\" srcset=\"https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/kiube-1024x681.png 1024w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/kiube-300x199.png 300w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/kiube-768x511.png 768w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/kiube.png 1122w\" sizes=\"auto, (max-width: 706px) 89vw, (max-width: 767px) 82vw, 740px\" \/><\/figure><\/div>\n\n\n\n<p>Cyclone\u00ae KIUBE with proton beam of 18 MeV can be equipped with commercially available solution for extraction of following isotopes: <sup>18<\/sup>F, <sup>68<\/sup>Ga, <sup>13<\/sup>N,<sup>15<\/sup>O, <sup>11<\/sup>C, <sup>64<\/sup>Cu, <sup>89<\/sup>Zr, <sup>99m<\/sup>Tc, <sup>124<\/sup>I, <sup>123<\/sup>I,<sup>67<\/sup>Ga, <sup>111<\/sup>In, <sup>86<\/sup>Y\u2026<\/p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:52% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"225\" src=\"http:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/synthera-1-300x225.png\" alt=\"\" class=\"wp-image-298 size-full\" srcset=\"https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/synthera-1-300x225.png 300w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/synthera-1-768x577.png 768w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/synthera-1.png 986w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p>IBA has in portfolio small, but very efficient and user friendly cartridge-based synthesis module Synthera\u00ae. It allows to simplify the production process and shortening synthesis times for compounds like: FDG, NaF, FLT, FCH, FMISO, FBB, FDOPA.<\/p>\n\n\n\n<p>Many more are available thorough user-to-user exchange community.<\/p>\n<\/div><\/div>\n\n\n\n<p>More details can be found:<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"http:\/\/www.iba-radiopharmasolutions.com\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"http:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/logo_iba-150x150.png\" alt=\"\" class=\"wp-image-287\" srcset=\"https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/logo_iba-150x150.png 150w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/logo_iba-300x300.png 300w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/logo_iba-100x100.png 100w, https:\/\/www.healthtech.pl\/wp-content\/uploads\/2019\/10\/logo_iba.png 359w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>IBA &#8211; Solution for radiopharmacy The IBA S.A. is present for more than 30 year on the market. It is a global leader for contemporary solutions for radio pharmacy and proton beam therapy. IBA\u2019s portfolio consists of wide range of cyclotrons for SPECT and PET radioisotope production with proton energy from 18 MeV up to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.healthtech.pl\/?page_id=375&#038;lang=en\" class=\"more-link\">Czytaj dalej<span class=\"screen-reader-text\"> IBA ENG<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-375","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=\/wp\/v2\/pages\/375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=375"}],"version-history":[{"count":5,"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=\/wp\/v2\/pages\/375\/revisions"}],"predecessor-version":[{"id":506,"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=\/wp\/v2\/pages\/375\/revisions\/506"}],"wp:attachment":[{"href":"https:\/\/www.healthtech.pl\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}